A- A A+

Kanada. Legaler Handel: Kanada kifft

Kanada gibt als erstes großes Industrieland Marihuana als Genussmittel frei. Die Branche hofft auf ein Milliardengeschäft – und die Börse ist im Rausch. (faz.net, 15.10.2018)


USA. Trump’s New Opioid Package Is Gift-Wrapped for Indivior—At What Cost?

On October 24, President Donald Trump signed a package of bills into law aimed at addressing the overdose crisis, dubbed the SUPPORT for Patients and Communities Act. But critics say it might as well be called the SUPPORT Indivior Act—a reference to the maker of Suboxone (active ingredients: buprenorphine and naloxone) and Sublocade, the recently approved injectable version of the drug, designed to last a month. (Indivior projects Sublocade’s annual sales will eventually reach $1 billion annually.) (Filter, USA, 29.10.2018)


Science without publication paywalls: cOAlition S for the realisation of full and immediate Open Access.

Schiltz M (2018) 

PLoS Biol 16(9): e3000031. https://doi.org/10.1371/journal.pbio.3000031


How to Regulate Cannabis: A Practical Guide

This is the second edition of our  guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world, who are witnessing the question change from, ‘Should we maintain cannabis prohibition?’ to ‘How will legal regulation work in practice?’ (Transform, UK, Oktober 2018)


USA. High-Nicotine E-Cigarettes Flood Market Despite FDA Rule

The sleek Juul electronic cigarettes have become a phenomenon at U.S. high schools, vexing educators and drawing regulatory scrutiny over their sweet flavors and high nicotine content. (Medscape, 26.09.2018)


Russland. Russia views opium poppy cultivation as response to sanctions 

A special commission of the Russian government has approved a draft law on the procedure for growing “narcotic” plants in Russia, in particular, the allowed varieties of hypnotic poppy (Papaver somniferum L). (...)

The Russian government’s website stresses that the international market for pharmaceutical substances for the production of opium drugs is controlled by a group of 10 companies, nine of which are under the jurisdiction of the states that imposed sanctions against Russia. (Belsat TV, Weißrussland, 23.10.2018)


USA. As opioid crisis rages, cost of overdose antidote spikes

As the opioid epidemic continues to kill tens of thousands of Americans each year, the drug naloxone has proved invaluable in preventing overdose-related deaths. Yet a spike in its cost in recent years has constrained access to naloxone, potentially depriving health care professionals, emergency responders and families of a critical treatment than can save lives. (CBS-News, Money Watch, USA, 14.08.2018)


Drogenbeauftragte für neuen Anlauf zu einem Tabakwerbeverbot

Hannover – Die Drogenbeauftragte der Bundesregierung, Marlene Mortler (CSU), hat einen neuen Anlauf für ein Verbot von Tabakwerbung auf Plakaten und im Kino gefordert. „Viel zu lange liegt das Tabakaußenwerbeverbot bereits auf Eis“, sagte Mortler den Zeitungen des Redaktionsnetzwerks Deutschland. Es sei Zeit, endlich mit den Diskussionen Schluss zu machen. (aerzteblatt.de, 17.10.2018)


USA. OxyContin maker gets patent for drug to treat opioid addiction

Purdue Pharma, the maker of OxyContin, has received a patent designed to treat opioid addiction.

The patent, first reported by The Financial Times, is for a new and faster-acting form of buprenorphine. (CBS-News, Money Watch, USA, 07.08.2018)


UK. Philip Morris accused of hypocrisy over anti-smoking ad

Image caption The campaign was launched in a four-page wraparound in the Daily Mirror

One of the world's biggest tobacco firms, Philip Morris, has been accused of "staggering hypocrisy" over its new ad campaign that urges smokers to quit. 

The Marlboro maker said the move was "an important next step" in its aim to "ultimately stop selling cigarettes". 

But Cancer Research UK said the firm was just trying to promote its smoking alternatives, such as heated tobacco. (BBC, UK, 22.10.2018)


USA. L'Oréal urged to rebrand 'breathtakingly insensitive' Black Opium fragrance by anti-drug group 

The National Council Against Drug Abuse accuses the beauty giant of "the height of cruelty" by attempting to profit while people are losing their lives to real opium. (Cosmetic Business, USA, 21.09.2018)


Marihuana „Made in Germany“ – FDP will Deutschland zur Cannabis-Exportnation machen 

Deutschland muss Medizinalhanf bislang importieren. Die FDP will das ändern – und die Bundesrepublik direkt zur Cannabis-Exportnation machen. (Handelsblatt, 16.10.2018)


Deutschland. Milliardeneinnahmen durch legales Cannabis: Kiffen für den Fiskus 

In Kanada gibt es ab Mitte Oktober legales Cannabis zu kaufen. Was würde eine Freigabe für die deutsche Volkswirtschaft bedeuten? Einer Studie zufolge könnte die Staatskasse ein Milliardenplus verbuchen. (Spiegel online, 24.09.2018)


USA. FDA investigating whether dozens of e-cigarette products are being illegally marketed

The Food and Drug Administration, in its latest effort to curb youth vaping, is investigating whether dozens of e-cigarette products are being sold illegally, the agency announced Friday. (Washington Post, 12.10.2018)


Cola mit Cannabis? Aurora-Aktionäre im Rausch - Coca-Cola signalisiert Interesse 

Ein Medienbericht über das mögliche Interesse von Coca-Cola hat Anleger des kanadischen Marihuana-Herstellers Aurora Cannabis in einen Kaufrausch versetzt. (Manager Magazin, 18.09.2018)


Jamaika/Kanada. Jamaica Makes First Shipment Of Medical Marijuana To Canada

Jamaica has made its first shipment of medical marijuana extract oil to Canada.

The shipment marks the first step in positioning Jamaica as the medical marijuana hub for the world.

In making the announcement, Minister of Industry, Commerce, Agriculture and Fisheries Audley Shaw, “Jamaica is uniquely positioned to be a global player and we are committed to providing the leadership and resources required for opening the international markets including Canada and Europe for our licensed and regulated Jamaican companies.” (Jamaica Gleaner, Jamaika, 27.09.2018)


USA/Kanada. Joint venture: Coca-Cola considers cannabis-infused range 

Soft drink maker in talks with Canadian marijuana producer about beverages to ease pain. (The Guardian, UK, 17.09.201)


Cannabis capitalism: who is making money in the marijuana industry? 

Marginalized groups that championed legalization struggle to compete with corporate refugees jumping on the bandwagon. (The Guardian, UK, 03.10.2018)


USA. Insurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore

The largest insurer in Tennessee has announced it will no longer cover prescriptions for what was once a blockbuster pain reliever. It’s the latest insurance company to turn against OxyContin, whose maker, Purdue Pharma, faces dozens of lawsuits related to its high-pressure sales tactics around the country and contribution to the opioid crisis. (Kaiser Health News, USA, 13.09.2018)


Publikationen in Räuberzeitschriften: Verharmlost und heruntergespielt

Dtsch Arztebl 2018; 115(40): A-1746 / B-1469 / C-1455

Antes, Gerd


Patent auf Hepatitis-Medikament bleibt mit Änderungen

München – Das US-Pharma-Unternehmen Gilead darf sein umstrittenes Patent auf ein Hepatitis-C-Medikament behalten – allerdings mit Änderungen. Das hat das Europäische Patentamt heute in München entschieden. Ärzte ohne Grenzen und Ärzte der Welt scheiterten demnach weitgehend mit ihrem Versuch, das Patent auf den Wirkstoff Sofosbuvir aufheben zu lassen. (aerzteblatt.de, 13.09.2018)


WHO fordert strikte Regulierung von Zigarettenalternativen

Genf – Die Tabakindustrie versucht nach Überzeugung der Weltgesundheitsorganisation (WHO), das Rauchen durch Alternativen zu herkömmlichen Zigaretten wieder salonfähig zu machen. E-Zigaretten und Tabakerhitzer müssten verboten oder streng reguliert werden, verlangt die Vorsitzende des Sekretariats der Anti-Tabak-Konvention der WHO, Vera Luiza da Costa e Silva in Genf. Dort beraten Vertreter der 181 Mitgliedsstaaten zurzeit unter anderem über den Umgang mit diesen neuen Produkten. (aerzteblatt.de, 05.10.2018)


Kanada. Kanadische Provinz verklagt Unternehmen wegen Opioid-Überdosen

Ottawa – Angesichts des grassierenden Missbrauchs von Opioiden hat die kanadische Provinz British Columbia mehr als 40 Hersteller und Vertreiber der Schmerzmittel auf Schadenersatz verklagt. Bei der ersten derartigen Klage von kanadischen Behörden gehe es um die Erstattung der Kosten von Notarzteinsätzen und Kranken­ausaufenthalten wegen Opioid-Überdosen, teilte der Justizminister der westkanadischen Provinz, David Eby, mit. Beschuldigt werden Hersteller, Großhändler und Vertreiber der starken Schmerzmittel. (aerzteblatt.de, 30.08.2018)


USA. F.D.A. Seizes Documents From Juul Headquarters

The Food and Drug Administration conducted a surprise inspection of the headquarters of the e-cigarette maker Juul Labs last Friday, carting away more than a thousand documents it said were related to the company’s sales and marketing practices. (New York Times, 02.10.2018)


USA. OxyContin Billionaire Patents New Drug for Opioid Treatment

In recent years, America’s pharmaceutical industry has taken it on the chin. Populist demagogues have savaged drug companies for “jacking up” the price of life-saving substances like insulin (a.k.a. honoring their fiduciary duty to maximize shareholder value). These boisterous neo-Bolsheviks will point to the fact that pharmaceuticals are several times more expensive in the U.S. than in other countries, and conclude that our government’s exceptionally strong patent laws — and aberrant refusal to push down drug prices through direct negotiation — are meant to enrich Big Pharma at the working American’s expense. (Daily Intelligencer, USA, 07.09.2018)


USA. JUUL laboratories have largest market share of E-cigarettes

(HealthDay)—From 2016 to 2017, sales of electronic cigarettes (e-cigarettes) by JUUL Laboratories increased 641 percent, with their sales comprising 29 percent of total e-cigarette sales by December 2017, according to a research letter published in the Oct. 2 issue of the Journal of the American Medical Association. (medicalxpress.com, USA, 04.10.2018)


USA. Purdue And The OxyContin Files

Purdue Pharma planned an extensive marketing campaign for the launch and promotion of the painkiller OxyContin. Here are Purdue’s internal budget documents from 1996 to 2002 — files released by the Florida attorney general’s office — that detail the company’s early strategy to sell and expand use of the drug. (Kaiser Health News, 13.06.2018)


High stakes: cannabis capitalists seek funds to drive drug trade - London conference pushes uses ranging from reducing pain to increasing orgasms

(...) The global cannabis industry has gathered in London this week for Europe’s largest marijuana investment conference, Cannabis Invest, with bosses of industrial-scale weed growers hoping to tap UK investors for fresh funds to drive expansion plans. (The Guardian, UK, 03.10.2018)